#H.I.G. Capital #London #United Kingdom #Healthcare Investments #ITH Group

H.I.G. Capital Completes the Acquisition of ITH Group Limited

H.I.G. Capital, a prominent global alternative investment firm with $70 billion in capital under management, has officially announced the completion of its acquisition of ITH Group Limited. This strategic move signifies H.I.G.'s commitment to enhancing their portfolio in the healthcare sector, particularly in specialized pharmaceutical services.

Established in the UK, ITH Group specializes in aseptic compounding, providing tailored injectable medication for patients with unique medical needs. Founded by industry professionals Adam Bloom and Karen Hamling, the company has carved a niche in the market, particularly in chemotherapy, total parenteral nutrition, and central intravenous additives. ITH Group prides itself on delivering high-quality, patient-centric medication, which is vital in ensuring the effectiveness of treatments for both adults and newborns. Additionally, the company operates a leading digital pharmacy that supplies critical, licensed medications to private patients and those covered under the National Health Service (NHS).

In a statement, Adam Bloom, CEO of ITH Group, expressed his enthusiasm about the partnership with H.I.G. He stated, “I am thrilled to welcome H.I.G. as a significant investor in the ITH Group. Since our inception in 2008, we have prioritized our people, allowing us to grow consistently and improve our service offerings to patients. We take pride in being a leading provider of compounding services in the UK, supporting both the NHS and private healthcare. We are determined to further expand our services in the future as we develop more expertise in delivering essential compounded medications.”

H.I.G. aims to collaborate closely with ITH's management team to not only support the company’s robust organic growth but also to enhance its production capacity. Adam Bloom and Karen Hamling will continue to lead ITH as CEO and COO, respectively.

John Harper, Managing Director and Head of H.I.G. Europe Lower Middle Market in London, remarked on the acquisition, saying, “We are excited to support Adam, Karen, and their team in continuing ITH's success. The company has a proven record of delivering dependable compounding services to NHS and private customers in a market that faces inherent shortages. With H.I.G.'s history in helping portfolio companies scale their capacity, ITH is embarking on an exciting new chapter.”

Gordon Cameron, Non-Executive Chairman of ITH, added, “The impressive company that Adam and Karen have built provides crucial services to the healthcare sector in the UK. It has established a leading reputation for reliability, placing high-quality customer service as a top priority. I am delighted to join the company as part of H.I.G.'s efforts to realize the next growth chapter.”

Since its inception in 2008, ITH has established itself with locations in London and has specialized in aseptic preparations for both NHS and private clients. Their focus on high-quality chemotherapy, total parenteral nutrition, and central intravenous additives has positioned them as leaders in the market.

H.I.G. Capital, headquartered in Miami, boasts a widespread global presence with offices across the United States and various international locations. The firm is noted for providing flexible, operationally focused capital to middle-market companies. H.I.G. typically invests in management buyouts, recapitalizations, and corporate carve-outs from both profitable and underperforming production and service companies.

The firm’s debt funds engage in senior, unitranche, and junior debt financing, catering to companies of all sizes on both a primary and secondary market basis. H.I.G. also manages a publicly traded BDC, WhiteHorse Finance, and engages in real estate investments that enhance property management practices. In addition, H.I.G. Infrastructure focuses on value-added investments and core investments in the infrastructure sector.

Since its formation in 1993, H.I.G. has invested in over 400 companies globally, currently comprising more than 100 companies with annual revenues exceeding $53 billion. For more information, visit H.I.G.'s website at hig.com.

Conclusion

The acquisition of ITH Group Limited marks a significant milestone for H.I.G. Capital, showcasing its dedication to expanding its investments in healthcare. By leveraging ITH's expertise and established reputation in the field of aseptic preparations, H.I.G. is poised to enhance its contribution to the healthcare landscape, ultimately benefiting countless patients in need of specialized medication.